N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

NCT00539513 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Researchers terminated study due to limited enrollment.

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: N-Acetylcysteine
DRUG: placebo

Sponsor

Yale University